-

Eurofins: Purchases of Own Shares From April 7th to April 11th 2025

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News:

Eurofins (Paris:ERF):

Name of the Issuer

Identity code of the Issuer

Day of the transaction

Identity code of the financial instrument

Total daily volume (in number of shares)

Daily weighted average purchase price of the shares

Market (MIC Code)

EUROFINS

529900JEHFM47DYY3S57

07/03/2025

FR0014000MR3

117,949

46.5566

XPAR

EUROFINS

529900JEHFM47DYY3S57

07/03/2025

FR0014000MR3

57,724

46.5835

CEUX

EUROFINS

529900JEHFM47DYY3S57

07/03/2025

FR0014000MR3

8,118

46.5843

TQEX

EUROFINS

529900JEHFM47DYY3S57

07/03/2025

FR0014000MR3

8,818

46.5950

AQEU

EUROFINS

529900JEHFM47DYY3S57

08/03/2025

FR0014000MR3

119,027

47.0631

XPAR

EUROFINS

529900JEHFM47DYY3S57

08/03/2025

FR0014000MR3

60,338

47.1450

CEUX

EUROFINS

529900JEHFM47DYY3S57

08/03/2025

FR0014000MR3

8,485

47.1454

TQEX

EUROFINS

529900JEHFM47DYY3S57

08/03/2025

FR0014000MR3

8,737

47.1471

AQEU

EUROFINS

529900JEHFM47DYY3S57

09/03/2025

FR0014000MR3

119,765

46.7822

XPAR

EUROFINS

529900JEHFM47DYY3S57

09/03/2025

FR0014000MR3

61,069

46.7989

CEUX

EUROFINS

529900JEHFM47DYY3S57

09/03/2025

FR0014000MR3

8,637

46.8098

TQEX

EUROFINS

529900JEHFM47DYY3S57

09/03/2025

FR0014000MR3

8,808

46.8186

AQEU

EUROFINS

529900JEHFM47DYY3S57

10/03/2025

FR0014000MR3

106,780

47.3397

XPAR

EUROFINS

529900JEHFM47DYY3S57

10/03/2025

FR0014000MR3

43,093

47.3135

CEUX

EUROFINS

529900JEHFM47DYY3S57

10/03/2025

FR0014000MR3

127

47.8500

AQEU

EUROFINS

529900JEHFM47DYY3S57

11/04/2025

FR0014000MR3

123,180

47.1516

XPAR

EUROFINS

529900JEHFM47DYY3S57

11/04/2025

FR0014000MR3

65,710

47.1966

CEUX

EUROFINS

529900JEHFM47DYY3S57

11/04/2025

FR0014000MR3

5,110

47.1921

TQEX

EUROFINS

529900JEHFM47DYY3S57

11/04/2025

FR0014000MR3

6,000

47.1954

AQEU

 

 

 

TOTAL

937,475

46.9760

 

Transaction details

In accordance with Article 5(1)(b) of Regulation (EU) N° 596/2014 (the Market Abuse Regulation) a full breakdown of the individual trades are disclosed on Eurofins Scientific SE website: https://www.eurofins.com/investors/share-buy-back-programmes

Contacts

Eurofins

Eurofins

BOURSE:ERF

Release Versions

Contacts

Eurofins

More News From Eurofins

Eurofins Announces the Cancellation of 10.8m Repurchased Shares

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (the “Company” or “Eurofins”) (EUFI.PA) (Paris:ERF) announces that its Board of Directors has decided on the cancellation of 10,818,183 shares, representing 5.61% of the Company’s share capital, that were repurchased as part of its share buyback programmes, which began in October 2022. The cancellation of shares is in line with, among other objectives, the Company’s intention to reduce the share capital as authorised by shareh...

Eurofins Scientific SE: Purchases of Own Shares from March 31st to April 4th 2025

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS 529900JEHFM47DYY3S57 31/03/2025 FR0014000MR3 102,000 49.2861 XPAR EUROFINS 529900JEHFM47DYY3S57 31/03/2025 FR0014000MR3 40,000 49.3084 CEUX EUROFINS 529900JEHFM47DYY3S57 31/03/2025 FR00...

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 March 2025

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal regulation of 11 January 2008 on transparency requirements for issuers of securities Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedi (including the issuer ID allocated by the CSSF) EUROFINS SCIENTIFIC SE – E1013 Identity of...
Back to Newsroom